Market Value338,325,000
Total Holdings58
File Date2023-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
INCY / Incyte Corporation
TGTX / TG Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
/ Fusion Networks Holdings, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call
PRVB / Provention Bio Inc
AADI / Aadi Bioscience, Inc.
XENE / Xenon Pharmaceuticals Inc.
ALT / Altimmune, Inc. Call
GERN / Geron Corporation
COGT / Cogent Biosciences, Inc.
SWTX / SpringWorks Therapeutics, Inc.
KZR / Kezar Life Sciences, Inc.
XFOR / X4 Pharmaceuticals, Inc.
QQQ / Invesco QQQ Trust, Series 1
IMGN / ImmunoGen, Inc.
BPMC / Blueprint Medicines Corporation
SRPT / Sarepta Therapeutics, Inc. Call
AGLE / Aeglea BioTherapeutics Inc
DSGN / Design Therapeutics, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MLTX / MoonLake Immunotherapeutics
VRDN / Viridian Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
VKTX / Viking Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
QURE / uniQure N.V.
ATXS / Astria Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
RVNC / Revance Therapeutics, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Call
SGEN / Seagen Inc
IRON / Disc Medicine, Inc.
AMAM / Ambrx Biopharma Inc.
SNDX / Syndax Pharmaceuticals, Inc.
RXDX / Prometheus Biosciences Inc
RAIN / Rain Enhancement Technologies Holdco, Inc.
BMEA / Biomea Fusion, Inc.
ETNB / 89bio, Inc. Call
VNDA / Vanda Pharmaceuticals Inc.
IOVA / Iovance Biotherapeutics, Inc.
ETNB / 89bio, Inc.
PFE / Pfizer Inc.
ACRS / Aclaris Therapeutics, Inc.
CTIC / CTI BioPharma Corp
FGEN / FibroGen, Inc.
RCUS / Arcus Biosciences, Inc.
JNJ / Johnson & Johnson
PTGX / Protagonist Therapeutics, Inc.
MRTX / Mirati Therapeutics, Inc.
ISEE / IVERIC bio Inc
RETA / Reata Pharmaceuticals Inc - Class A Call
RETA / Reata Pharmaceuticals Inc - Class A
FOLD / Amicus Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
BBIO / BridgeBio Pharma, Inc.
RAPT / RAPT Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.